| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |